SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-20-005509
Filing Date
2020-06-05
Accepted
2020-06-05 17:43:42
Documents
1
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT allo-form4_060320.html 4  
1 OWNERSHIP DOCUMENT allo-form4_060320.xml 4 13292
  Complete submission text file 0001387131-20-005509.txt   15597
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 20947495

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
COULTER JAMES G (Reporting) CIK: 0001099776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 20947496

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Reporting) CIK: 0001495741 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 20947494

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences